{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:19:52Z","timestamp":1780687192984,"version":"3.54.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.yexcr.2023.113681","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T20:39:37Z","timestamp":1686602377000},"page":"113681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells"],"prefix":"10.1016","volume":"429","author":[{"given":"Parisa","family":"Vasefifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souzan","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouhollah","family":"Motafakkerazad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Safaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basira","family":"Najafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Alemohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Jafarlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Baradaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib1","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s10555-020-09925-3","article-title":"Gastric cancer: a comprehensive review of current and future treatment strategies","volume":"39","author":"Sexton","year":"2020","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.yexcr.2023.113681_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2147\/CMAR.S149619","article-title":"Gastric cancer: epidemiology, prevention, classification, and treatment","volume":"10","author":"Sitarz","year":"2018","journal-title":"Cancer Manag. Res."},{"issue":"10251","key":"10.1016\/j.yexcr.2023.113681_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.yexcr.2023.113681_bib4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/cancers14020290","article-title":"Claudins and gastric cancer: an overview","volume":"14","author":"Hashimoto","year":"2022","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.yexcr.2023.113681_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/apm.12359","article-title":"Targeted therapy in gastric cancer","volume":"123","author":"Thiel","year":"2015","journal-title":"APMIS (Acta Pathol. Microbiol. Immunol. Scand.)"},{"issue":"1","key":"10.1016\/j.yexcr.2023.113681_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4252\/wjsc.v14.i1.76","article-title":"Molecular mechanism of therapeutic approaches for human gastric cancer stem cells","volume":"14","author":"Hsieh","year":"2022","journal-title":"World J. Stem Cell."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib7","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/jcp.30063","article-title":"The oncogenic potential of NANOG: an important cancer induction mediator","volume":"236","author":"Najafzadeh","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.yexcr.2023.113681_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s12032-011-9860-9","article-title":"Overexpression of Nanog protein is associated with poor prognosis in gastric adenocarcinoma","volume":"29","author":"Lin","year":"2012","journal-title":"Med. Oncol."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib9","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/jcp.30063","article-title":"The oncogenic potential of NANOG: an important cancer induction mediator","volume":"236","author":"Najafzadeh","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"10.1016\/j.yexcr.2023.113681_bib10","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1002\/hed.26373","article-title":"Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin\u2010resistance, invasion and stemness acquisition","volume":"42","author":"Kashyap","year":"2020","journal-title":"Head Neck"},{"issue":"9","key":"10.1016\/j.yexcr.2023.113681_bib11","doi-asserted-by":"crossref","first-page":"14935","DOI":"10.3390\/ijms150914935","article-title":"Enhanced chemosensitivity by targeting Nanog in head and neck squamous cell carcinomas","volume":"15","author":"Huang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.yexcr.2023.113681_bib12","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00432-012-1253-8","article-title":"Nanog siRNA plus Cisplatin may enhance the sensitivity of chemotherapy in esophageal cancer","volume":"138","author":"Du","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2023.113681_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.yexcr.2023.113681_bib14","first-page":"1","article-title":"Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.yexcr.2023.113681_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2023.113681_bib16","article-title":"Recent progress in gastric cancer prevention","volume":"50\u201351","author":"Park","year":"2021","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"issue":"1","key":"10.1016\/j.yexcr.2023.113681_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15384047.2015.1121348","article-title":"The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells","volume":"17","author":"Gawlik-Rzemieniewska","year":"2016","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.suronc.2013.08.001","article-title":"Nanog, a novel prognostic marker for lung cancer","volume":"22","author":"Du","year":"2013","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.4161\/cbt.9.4.10666","article-title":"Over-expression of Nanog predicts tumor progression and poor prognosis in colorectal cancer","volume":"9","author":"Meng","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.yexcr.2023.113681_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-2.14673","article-title":"NANOG as prognostic factor of prostate cancer course","volume":"42","author":"Zadvornyi","year":"2020","journal-title":"Exp. Oncol."},{"issue":"2","key":"10.1016\/j.yexcr.2023.113681_bib21","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.34172\/ipp.2020.21","article-title":"Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines","volume":"6","author":"Aliyari-Serej","year":"2020","journal-title":"Immunopathologia Persa"},{"key":"10.1016\/j.yexcr.2023.113681_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejphar.2019.03.003","article-title":"New insight into NANOG: a novel therapeutic target for ovarian cancer (OC)","volume":"852","author":"Mahalaxmi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.yexcr.2023.113681_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3892\/ol_00000081","article-title":"The human pluripotency gene NANOG\/NANOGP8 is expressed in gastric cancer and associated with tumor development","volume":"1","author":"Zhang","year":"2010","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1159\/000341471","article-title":"Increased Nanog expression promotes tumor development and Cisplatin resistance in human esophageal cancer cells","volume":"30","author":"Yang","year":"2012","journal-title":"Cell. Physiol. Biochem. : Int. J. Experim. Cellular Physiol., Biochem., Pharmacol."},{"key":"10.1016\/j.yexcr.2023.113681_bib25","article-title":"Silencing of Nanog as a promising therapeutic approach against liver cancer; how this silencing could increase the sensitivity to Cisplatin","author":"Alemohammad","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2023.113681_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173871","article-title":"Suppression of Nanog inhibited cell migration and increased the sensitivity of colorectal cancer cells to 5-fluorouracil","volume":"894","author":"Khosravi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.yexcr.2023.113681_bib27","doi-asserted-by":"crossref","first-page":"9671","DOI":"10.1007\/s13277-016-4848-x","article-title":"NANOG regulates epithelial-mesenchymal transition and chemo-resistance through activation of the STAT3 pathway in epithelial ovarian cancer","volume":"37","author":"Liu","year":"2016","journal-title":"Tumor Biol."},{"issue":"1","key":"10.1016\/j.yexcr.2023.113681_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10863-4","article-title":"Breast cancer spheroids reveal a differential cancer stem cell response to chemotherapeutic treatment","volume":"7","author":"Reynolds","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.yexcr.2023.113681_bib29","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.3892\/ijo.2014.2347","article-title":"Knockdown of NANOG enhances chemosensitivity of liver cancer cells to doxorubicin by reducing MDR1 expression","volume":"44","author":"Zhou","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2023.113681_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2022.146333","article-title":"siRNA-mediated silencing of Nanog reduces stemness properties and increases the sensitivity of HepG2 cells to Cisplatin","volume":"821","author":"Alemohammad","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2023.113681_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145844","article-title":"NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer","volume":"801","author":"Serej","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.yexcr.2023.113681_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153869","article-title":"Nanog suppression enhanced the chemosensitivity of human non-small-cell lung cancer cells to Cisplatin and inhibited cell migration","volume":"233","author":"Najafzadeh","year":"2022","journal-title":"Pathol. Res. Pract."},{"issue":"7","key":"10.1016\/j.yexcr.2023.113681_bib33","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/156800905774574048","article-title":"Cancer therapy through control of cell migration","volume":"5","author":"Levin","year":"2005","journal-title":"Curr. Cancer Drug Targets"},{"issue":"20","key":"10.1016\/j.yexcr.2023.113681_bib34","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/onc.2013.209","article-title":"The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis","volume":"33","author":"Lu","year":"2014","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.yexcr.2023.113681_bib35","doi-asserted-by":"crossref","first-page":"889","DOI":"10.5114\/aoms.2015.55368","article-title":"Silencing expression of the NANOG gene and changes in migration and metastasis of urinary bladder cancer cells","volume":"12","author":"Gawlik-Rzemieniewska","year":"2016","journal-title":"Arch. Med. Sci.: AMS"},{"issue":"30","key":"10.1016\/j.yexcr.2023.113681_bib36","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1038\/onc.2012.363","article-title":"Stem cell transcription factor NANOG controls cell migration and invasion via dysregulation of E-cadherin and FoxJ1 and contributes to adverse clinical outcome in ovarian cancers","volume":"32","author":"Siu","year":"2013","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.yexcr.2023.113681_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.biocel.2013.02.017","article-title":"NANOG promotes liver cancer cell invasion by inducing epithelial\u2013mesenchymal transition through NODAL\/SMAD3 signaling pathway","volume":"45","author":"Sun","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.yexcr.2023.113681_bib38","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1159\/000485405","article-title":"Reduction of NANOG mediates the inhibitory effect of aspirin on tumor growth and stemness in colorectal cancer","volume":"44","author":"Wang","year":"2017","journal-title":"Cell. Physiol. Biochem."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272300229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448272300229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:22:17Z","timestamp":1762147337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448272300229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S001448272300229X"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113681","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2023.113681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113681"}}